University of Osijek
13 imported, source-linked research records. All imported publication dates.
13 matching research records
Topic: Canagliflozin and SGLT2. Only records linked to University of Osijek are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.
Showing 1–13 of 13 matching records. Counts update as records arrive.
γδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes
September 11, 2026 · 0 citations · Open access
Open original record →Hemoglobin Trajectories on SGLT2 Inhibitor Therapy in Heart Failure: Anemia Marks Adverse Prognosis While Erythrocytosis Is Transient and Not Associated with Adverse Outcomes
July 13, 2026 · 0 citations · Open access
Open original record →Impact of Antidiabetic Medications on IgG and Plasma Protein N-Glycosylation in Type 2 Diabetes Patients
June 22, 2026 · 0 citations · Open access
Open original record →Heart Failure Etiology and 6-Month Cardiorenal Recovery Patterns After Early In-Hospital SGLT2 Inhibitor Initiation in HFrEF: A Prospective Real-World Cohort
May 24, 2026 · 1 citations · Open access
Open original record →GLP-1 Receptor Agonist Semaglutide and SGLT2 Inhibitors after Acute Coronary Syndrome in Patients with Diabetes: Real-World Comparative Outcomes from an Observational Registry
April 14, 2026 · 0 citations
Open original record →#2549 Real world data of dapagliflozin effect on proteinuria in primary glomerulopathies in Croatia
May 1, 2024 · 1 citations · Open access
Open original record →A Patient-Centered Management of Patients with Diabetes Type 2: Are All Diabetic Patients the Same?
October 27, 2023 · 0 citations · Open access
Open original record →Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy
October 16, 2023 · 10 citations · Open access
Open original record →Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients
September 30, 2023 · 6 citations · Open access
Open original record →Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging
August 29, 2023 · 78 citations · Open access
Open original record →Exploring new treatment options for polycystic ovary syndrome: Review of a novel antidiabetic agent SGLT2 inhibitor
July 12, 2021 · 35 citations · Open access
Open original record →Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes
October 23, 2020 · 164 citations · Open access
Open original record →Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era
May 14, 2020 · 88 citations · Open access
Open original record →